BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu P, Jia F, Zhang B, Zhang P. Risk of cardiovascular disease in inflammatory bowel disease. Exp Ther Med 2017;13:395-400. [PMID: 28352306 DOI: 10.3892/etm.2016.3966] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Rahman SU, Li Y, Huang Y, Zhu L, Feng S, Wu J, Wang X. Treatment of inflammatory bowel disease via green tea polyphenols: possible application and protective approaches. Inflammopharmacol 2018;26:319-30. [DOI: 10.1007/s10787-018-0462-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
2 Papada E, Forbes A, Amerikanou C, Torović L, Kalogeropoulos N, Tzavara C, Triantafillidis JK, Kaliora AC. Antioxidative Efficacy of a Pistacia Lentiscus Supplement and Its Effect on the Plasma Amino Acid Profile in Inflammatory Bowel Disease: A Randomised, Double-Blind, Placebo-Controlled Trial. Nutrients 2018;10:E1779. [PMID: 30453494 DOI: 10.3390/nu10111779] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Zhang Y, Hao X, Zheng X, Zhao H, Zhang W, Zhang L. Acute myocardial infarction in a young woman with ulcerative colitis: A case report and literature review. Medicine (Baltimore) 2017;96:e8885. [PMID: 29382015 DOI: 10.1097/MD.0000000000008885] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Ng AC. Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis. J Crohns Colitis 2021;15:1774. [PMID: 33822914 DOI: 10.1093/ecco-jcc/jjab062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Martínez-Hervás S, González-Navarro H. Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms. Rev Esp Cardiol (Engl Ed) 2019;72:767-73. [PMID: 31155366 DOI: 10.1016/j.rec.2019.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Soroush A, Shams-Alizadeh N, Vahdat A, Mohebi Z, Saeidi M, Komasi S. Role of perceived heart risk factors by outpatient population in predicting cardiovascular risk. J Cardiovasc Thorac Res 2019;11:100-8. [PMID: 31384403 DOI: 10.15171/jcvtr.2019.18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Nocerino A, Feathers A, Ivanina E, Durbin L, Swaminath A. Mortality Risk of Inflammatory Bowel Disease: A Case–Control Study of New York State Death Records. Dig Dis Sci 2019;64:1604-11. [DOI: 10.1007/s10620-018-5430-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
8 Tanislav C, Trommer K, Labenz C, Kostev K. Inflammatory Bowel Disease as a Precondition for Stroke or TIA: A Matter of Crohn's Disease Rather than Ulcerative Colitis. J Stroke Cerebrovasc Dis 2021;30:105787. [PMID: 33865232 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105787] [Reference Citation Analysis]
9 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Reference Citation Analysis]
10 Gamah M, Alahdal M, Zhang Y, Zhou Y, Ji Q, Yuan Z, Han Y, Shen X, Ren Y, Zhang W. High-altitude hypoxia exacerbates dextran sulfate sodium (DSS)-induced colitis by upregulating Th1 and Th17 lymphocytes. Bioengineered 2021;12:7985-94. [PMID: 34666625 DOI: 10.1080/21655979.2021.1975017] [Reference Citation Analysis]
11 Marotto D, Atzeni F, Ardizzone S, Monteleone G, Giorgi V, Sarzi-Puttini P. Extra-intestinal manifestations of inflammatory bowel diseases. Pharmacol Res 2020;161:105206. [PMID: 32998068 DOI: 10.1016/j.phrs.2020.105206] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Brown E, Taylor CT. Hypoxia-sensitive pathways in intestinal inflammation. J Physiol 2018;596:2985-9. [PMID: 29114885 DOI: 10.1113/JP274350] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
13 Brnić D, Martinovic D, Zivkovic PM, Tokic D, Tadin Hadjina I, Rusic D, Vilovic M, Supe-Domic D, Tonkic A, Bozic J. Serum adropin levels are reduced in patients with inflammatory bowel diseases.Sci Rep. 2020;10:9264. [PMID: 32518265 DOI: 10.1038/s41598-020-66254-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wylezinski LS, Gray JD, Polk JB, Harmata AJ, Spurlock CF 3rd. Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. J Clin Med 2019;8:E493. [PMID: 30979036 DOI: 10.3390/jcm8040493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Zanoni P, Velagapudi S, Yalcinkaya M, Rohrer L, von Eckardstein A. Endocytosis of lipoproteins. Atherosclerosis 2018;275:273-95. [PMID: 29980055 DOI: 10.1016/j.atherosclerosis.2018.06.881] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
16 Chen Y, Wang X. Increased risk of stroke among patients with inflammatory bowel disease: A PRISMA-compliant meta-analysis. Brain Behav 2021;11:e02159. [PMID: 33960728 DOI: 10.1002/brb3.2159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Stone CR, Mickle AT, Boyne DJ, Mohamed A, Rabi DM, Brenner DR, Friedenreich CM. Treatment for lymphoma and late cardiovascular disease risk: A systematic review and meta-analysis. Health Sci Rep 2019;2:e135. [PMID: 31667360 DOI: 10.1002/hsr2.135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
18 Williams JW, Huang LH, Randolph GJ. Cytokine Circuits in Cardiovascular Disease. Immunity 2019;50:941-54. [PMID: 30995508 DOI: 10.1016/j.immuni.2019.03.007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 17.0] [Reference Citation Analysis]
19 Calabriso N, Massaro M, Scoditti E, Verri T, Barca A, Gerardi C, Giovinazzo G, Carluccio MA. Grape Pomace Extract Attenuates Inflammatory Response in Intestinal Epithelial and Endothelial Cells: Potential Health-Promoting Properties in Bowel Inflammation. Nutrients 2022;14:1175. [DOI: 10.3390/nu14061175] [Reference Citation Analysis]
20 Venancio VP, Kim H, Sirven MA, Tekwe CD, Honvoh G, Talcott ST, Mertens-Talcott SU. Polyphenol-rich Mango (Mangifera indica L.) Ameliorate Functional Constipation Symptoms in Humans beyond Equivalent Amount of Fiber. Mol Nutr Food Res 2018;62:e1701034. [PMID: 29733520 DOI: 10.1002/mnfr.201701034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
21 He P, Fan SY, Guan JQ, Song WJ, Obore N, Chen WQ, Zhi H, Wang LN. Mediation analysis for the relationship between dyslipidemia and coronary artery disease via hypersensitive C-reactive protein in a case-control study. Coron Artery Dis 2020;31:613-9. [PMID: 32452886 DOI: 10.1097/MCA.0000000000000911] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
22 Labarca G, Drake L, Horta G, Jantz MA, Mehta HJ, Fernandez-Bussy S, Folch E, Majid A, Picco M. Association between inflammatory bowel disease and chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMC Pulm Med 2019;19:186. [PMID: 31660921 DOI: 10.1186/s12890-019-0963-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
23 Ferreira-Duarte M, Sousa JB, Diniz C, Sousa T, Duarte-Araújo M, Morato M. Experimental and Clinical Evidence of Endothelial Dysfunction in Inflammatory Bowel Disease. Curr Pharm Des 2020;26:3733-47. [PMID: 32611296 DOI: 10.2174/1381612826666200701212414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Persaud A, Ahmed A, Kakked G, Shulik O, Ahlawat S. Association of Autoimmune Hepatitis and Cardiovascular Disease. Digestive and Liver Disease 2019;51:1604-9. [DOI: 10.1016/j.dld.2019.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
25 Pohanka M. Piezoelectric biosensor for the determination of Tumor Necrosis Factor Alpha. Talanta 2018;178:970-3. [PMID: 29136925 DOI: 10.1016/j.talanta.2017.10.031] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 6.4] [Reference Citation Analysis]
26 Boussi L, Safaya A, Goyal A, Mateo R, Laskowski I, Babu S. "Inflammatory Bowel Disease-Not Just the Bowel's Bane": Peripheral Arterial and Venous Thrombosis in a Patient With Crohn Disease. Vasc Endovascular Surg 2020;54:646-9. [PMID: 32638640 DOI: 10.1177/1538574420939360] [Reference Citation Analysis]
27 Kamp KJ, Stommel M. Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease: A Case Control Study. Gastroenterol Nurs 2021;44:21-30. [PMID: 33351519 DOI: 10.1097/SGA.0000000000000491] [Reference Citation Analysis]
28 Bandyopadhyay D, Jain V, Hajra A, Chakraborty S, Ghosh RK, Herzog E. Effects of inflammatory bowel disease on in-hospital outcomes in patients with congestive heart failure: A retrospective national inpatient sample study. Int J Cardiol Heart Vasc 2019;23:100355. [PMID: 31008180 DOI: 10.1016/j.ijcha.2019.100355] [Reference Citation Analysis]
29 Lamb FS, Choi H, Miller MR, Stark RJ. TNFα and Reactive Oxygen Signaling in Vascular Smooth Muscle Cells in Hypertension and Atherosclerosis. Am J Hypertens 2020;33:902-13. [PMID: 32498083 DOI: 10.1093/ajh/hpaa089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
30 Pepe M, Cecere A, D’alessandro P, Fumarola F, Ciccone MM, Marchese A, Guaricci AI, Giordano A, Bortone AS, Favale S. Massive stent thrombosis during active ulcerative colitis: the tricky balance between manifest hemorrhagic and concealed thrombotic risk. Clin Exp Med 2018;18:481-5. [DOI: 10.1007/s10238-018-0522-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
31 Szczeklik K, Mach T, Cibor D, Owczarek D, Sapa J, Papież M, Pytko-Polończyk J, Krzyściak W. Correlation of Paraoxonase-1 with the Severity of Crohn's Disease. Molecules 2018;23:E2603. [PMID: 30314292 DOI: 10.3390/molecules23102603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Pokusaeva DP, Anikhovskaya IA, Korobkova LA, Enukidze GG, Yakovlev MY. Prognostic Importance of Systemic Endotoxinemia Indicators in Atherogenesis. Hum Physiol 2019;45:543-51. [DOI: 10.1134/s036211971905013x] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Cichoń N, Czarny P, Bijak M, Miller E, Śliwiński T, Szemraj J, Saluk-Bijak J. Benign Effect of Extremely Low-Frequency Electromagnetic Field on Brain Plasticity Assessed by Nitric Oxide Metabolism during Poststroke Rehabilitation. Oxid Med Cell Longev 2017;2017:2181942. [PMID: 29138675 DOI: 10.1155/2017/2181942] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]